IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 112 filers reported holding IMMUNOMEDICS INC in Q2 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $322,000 | +138.5% | 49,800 | +35.3% | 0.09% | +119.5% |
| Q4 2016 | $135,000 | +114.3% | 36,800 | +88.7% | 0.04% | +127.8% |
| Q3 2016 | $63,000 | +40.0% | 19,500 | 0.0% | 0.02% | +260.0% |
| Q2 2016 | $45,000 | -64.0% | 19,500 | -36.5% | 0.01% | -85.3% |
| Q2 2015 | $125,000 | +5.9% | 30,695 | 0.0% | 0.03% | -24.4% |
| Q1 2015 | $118,000 | -19.7% | 30,695 | 0.0% | 0.04% | -26.2% |
| Q4 2014 | $147,000 | +28.9% | 30,695 | 0.0% | 0.06% | +22.0% |
| Q3 2014 | $114,000 | +1.8% | 30,695 | 0.0% | 0.05% | -2.0% |
| Q2 2014 | $112,000 | -13.2% | 30,695 | 0.0% | 0.05% | -20.3% |
| Q1 2014 | $129,000 | -8.5% | 30,695 | 0.0% | 0.06% | -19.0% |
| Q4 2013 | $141,000 | +38.2% | 30,695 | +105.8% | 0.08% | +27.4% |
| Q3 2013 | $102,000 | +25.9% | 14,918 | 0.0% | 0.06% | +31.9% |
| Q2 2013 | $81,000 | – | 14,918 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |